Seneca Partners

Seneca Partners is a middle market-focused investment banking and private investment firm established in 2002 and located in Southfield, Michigan. The firm offers a range of services, including mergers, acquisitions, joint ventures, recapitalization, project finance, and capital raising through both debt and equity. While Seneca Partners has expertise across various industry sectors, it particularly excels in manufacturing, healthcare, business services, technology, information technology, and specialty finance. As an independent sponsor, Seneca actively targets lower-middle market investment opportunities, collaborating closely with family offices and institutional capital partners to invest in profitable businesses primarily located in the U.S. and Canada.

Tyler Crook

Senior Associate

Edward Mollison

Senior Associate

Chris Scagnetti

Senior Associate

Michael C. Skaff

Managing Director

Tony Zambelli

Co-Founder and Managing Director

17 past transactions

Vivos Therapeutics

Post in 2024
Vivos Therapeutics, Inc. is a medical technology company based in Highlands Ranch, Colorado, focused on developing and commercializing innovative solutions for patients suffering from sleep disordered breathing, particularly mild to moderate obstructive sleep apnea (OSA). The company's flagship offering, the Vivos System, provides a non-surgical, non-invasive, and cost-effective treatment that utilizes customized oral appliances and specialized treatment protocols to modify the size, shape, and position of airway tissues. This approach aims to open airway space and alleviate symptoms associated with OSA. Vivos Therapeutics also supports its network of healthcare providers, including general dentists and medical professionals, by offering training and access to its technology. Additionally, the company licenses its intellectual property to third-party manufacturers for the production of appliance devices. Established in 2007, Vivos Therapeutics has positioned itself as a leader in addressing sleep disordered breathing in the United States and Canada.

ADC Biotechnology

Venture Round in 2018
ADC Biotechnology Ltd specializes in the development of innovative antibody-drug conjugates (ADCs) aimed at treating cancer. Based in St Asaph, United Kingdom, the company has developed a patented Lock-Release technology that streamlines the purification process for ADCs, significantly reducing the number of steps and associated risks in drug production. In addition to its proprietary technology, ADC Biotechnology offers consultancy and research and development services to support drug developers and manufacturers in overcoming challenges related to conjugation processes. Since its establishment in 2010, the company has focused on delivering faster and more cost-effective solutions in the oncology field, facilitating the advancement of targeted therapies for cancer treatment.

SuperCarers

Series A in 2018
SuperCarers is a service that assists families in finding suitable home care by connecting them with independent caregivers. Based in Warrington, United Kingdom, the platform offers a personal matchmaking service that simplifies the care journey for families, allowing them to manage scheduling, logistics, and payments directly with caregivers. SuperCarers provides a range of care options, including live-in care, daycare, night care, respite care, and specialized support for conditions such as dementia, Alzheimer's, cancer, and mobility issues. By facilitating direct connections between care seekers and trusted local carers, SuperCarers aims to help families save money while ensuring that caregivers earn a living wage.

BondMason

Venture Round in 2018
BondMason Ltd operates an online investment platform that facilitates peer-to-peer (P2P) and direct lending in the United Kingdom. Founded in 2014 and based in Harpenden, the company focuses on providing investors with access to the UK property market through P2P loan investments. The platform helps users select and diversify their loan investments, aiming to optimize their returns. By sourcing loans from approved platforms, BondMason enables clients to purchase cash receipts from underlying P2P loans and receivables, thereby enhancing their potential for annual investment returns.

ADC Biotechnology

Venture Round in 2017
ADC Biotechnology Ltd specializes in the development of innovative antibody-drug conjugates (ADCs) aimed at treating cancer. Based in St Asaph, United Kingdom, the company has developed a patented Lock-Release technology that streamlines the purification process for ADCs, significantly reducing the number of steps and associated risks in drug production. In addition to its proprietary technology, ADC Biotechnology offers consultancy and research and development services to support drug developers and manufacturers in overcoming challenges related to conjugation processes. Since its establishment in 2010, the company has focused on delivering faster and more cost-effective solutions in the oncology field, facilitating the advancement of targeted therapies for cancer treatment.

Redag Crop

Venture Round in 2017
Redag Crop Protection specializes in developing innovative crop protection products, including fungicides, herbicides, insecticides, and nematicides. Utilizing a proprietary method known as the Redox Switch™, the company enhances existing crop protection solutions and identifies new intellectual properties to create effective agrochemicals. This approach not only shortens development cycles but also addresses the urgent need for novel products in the agrochemical sector, as traditional options are increasingly withdrawn due to safety concerns or reduced efficacy from pest resistance. By focusing on sustainable food production, Redag Crop Protection aims to enable farmers to better safeguard their crops from pests, thereby contributing to agricultural innovation and sustainability.

Vapour Media

Venture Round in 2017
Vapour Cloud is a West Yorkshire cloud technology provider to SME resellers. Vapour provides SME resellers with the point of access to highly competent independent, private network infrastructure, a choice of leading network providers, and a scalable platform for growth, backed by comprehensive training and fully managed installation and support.

Vapour Media

Venture Round in 2016
Vapour Cloud is a West Yorkshire cloud technology provider to SME resellers. Vapour provides SME resellers with the point of access to highly competent independent, private network infrastructure, a choice of leading network providers, and a scalable platform for growth, backed by comprehensive training and fully managed installation and support.

Redag Crop

Venture Round in 2016
Redag Crop Protection specializes in developing innovative crop protection products, including fungicides, herbicides, insecticides, and nematicides. Utilizing a proprietary method known as the Redox Switch™, the company enhances existing crop protection solutions and identifies new intellectual properties to create effective agrochemicals. This approach not only shortens development cycles but also addresses the urgent need for novel products in the agrochemical sector, as traditional options are increasingly withdrawn due to safety concerns or reduced efficacy from pest resistance. By focusing on sustainable food production, Redag Crop Protection aims to enable farmers to better safeguard their crops from pests, thereby contributing to agricultural innovation and sustainability.

Evgen Pharma

Venture Round in 2015
Evgen Pharma is a clinical stage drug development company headquartered in Wilmslow, United Kingdom, focused on creating sulforaphane-based medicines for various diseases, particularly cancer and neurological conditions. The company's proprietary technology, Sulforadex, consists of synthetic and stabilized analogues of sulforaphane, a compound recognized for its potential therapeutic benefits. Evgen's lead product, SFX-01, is a synthetic version of sulforaphane that is currently undergoing Phase II clinical trials for metastatic breast cancer and subarachnoid hemorrhage. Additionally, SFX-01 is in preclinical development for multiple sclerosis and is also being studied for its efficacy in treating prostate cancer, autism, non-alcoholic steatohepatitis, and chronic kidney diseases. Founded in 2007, Evgen Pharma aims to transform scientific research into commercially viable treatments.

The Insurance Surgery

Acquisition in 2015
The Insurance Surgery Ltd. specializes in providing life insurance, travel insurance, and financial solutions for individuals with pre-existing medical conditions and high-risk profiles in the United Kingdom. Established in 1999 and based in Macclesfield, the company caters to a range of medical conditions, including diabetes, multiple sclerosis, cancer, epilepsy, and asthma. Its offerings encompass various products such as life and travel insurance tailored for specific health issues, enhanced annuities, income protection, critical illness insurance, and general financial advice. The Insurance Surgery is recognized for its commitment to customer service and has garnered high ratings for client satisfaction. The company aims to ensure that clients receive appropriate cover tailored to their unique health circumstances and financial needs, thus helping them secure their financial futures.

Rockar

Seed Round in 2014
Rockar Limited is a UK-based online car retailer that offers a comprehensive e-commerce platform for car buying. Established in 2011, the company allows customers to seamlessly search for vehicles, sell their old cars, and customize financing options from the comfort of their homes. Rockar's website facilitates a user-friendly experience where customers can build their desired vehicles and track their delivery. The company emphasizes customer empowerment and provides knowledgeable support through its "Rockar Angels," who offer assistance without being pushy. This innovative approach aims to eliminate the traditional pressures associated with car sales, providing straightforward advice and transparent pricing to ensure a stress-free purchasing journey.

myParcelDelivery

Seed Round in 2014
myParcelDelivery.com is the brainchild of two young and exciting entrepreneurs Paul Haydock and David Grimes. They both had the idea whilst trying to negotiate reasonable courier rates for another business, coupled with many hours waiting in the local post office. The realisation quickly dawned that it was not only businesses that needed access to reliable, trackable and cost effective courier services - but also small retailers, eBay Sellers and the general public. David and Paul then embarked on a 20 month development program to design a website that could perform beyond any perceivable competition. The result is myParcelDelivery.com™, which is focused on saving you time and money when sending (and receiving!) parcels. Every function of myParcelDelivery.com™ culminates in your successful sending of a UK based, or indeed an international parcel delivery. With an incredible team effort, our IT department has raised the bar in development standards to ensure that what we do is right for you. Our young and innovative team thrive on out-smarting our competitors in all areas, which has lead to the company racking up award after award (which you can read all about by following the links to the right)!

Cytox

Series A in 2014
Cytox Limited specializes in developing products and services aimed at diagnosing and treating neurodegenerative disorders, particularly Alzheimer's disease. The company has created a genetic-based blood test that assesses the risk and diagnosis of Alzheimer's in its early stages, addressing a critical need as the prevalence of the disease rises globally. Cytox's offerings include cellular and genetic assays for identifying cell cycle deficits in patients, along with biomarker and drug-screening services for pharmaceutical companies engaged in clinical trials. The company collaborates with Affymetrix, part of Thermo Fisher Scientific, to enhance its commercial testing capabilities. Founded in 2004 and headquartered in Birmingham, United Kingdom, with additional offices in Manchester and Oxford, Cytox serves pharmaceutical and biotechnology firms, as well as research laboratories involved in clinical research and drug development.

Celleration

Series E in 2011
Celleration Inc. is a medical device company based in Eden Prairie, Minnesota, founded in 1999. The company specializes in developing and commercializing therapeutic ultrasound technologies for wound care. Its flagship product, the MIST Therapy System, employs low-frequency ultrasound delivered through a saline mist to promote healing by penetrating the wound bed and stimulating cellular activity. Unlike traditional wound treatments, which primarily address the surface, MIST Therapy targets deeper layers to enhance the healing process. Celleration received FDA clearance for this therapy in 2005 and has successfully introduced it to the U.S. market, demonstrating significant clinical and economic benefits across numerous healthcare facilities. To date, over one million MIST Therapy treatments have been administered, positively impacting the lives of more than 65,000 patients. The company operates as a subsidiary of Alliqua BioMedical, Inc.

Adesso AI

Venture Round in 2010
Adesso AI is a technology solutions provider that specializes in trade promotion and deduction management software for the Consumer Goods industry. Founded in 2002, the company leverages a powerful AI engine and real-time data to enhance the effectiveness of trade promotions for small and medium-sized businesses. Unlike typical software firms, Adesso AI is staffed by trade experts with extensive experience in major consumer packaged goods companies, which enables them to deliver tailored insights and support. Their platform helps clients measure and improve trade promotion effectiveness, manage trade spending, and resolve deductions, all while focusing on client profitability. Additionally, Adesso AI offers dedicated support to assist businesses in achieving their trade management and broader operational goals.

WebPutty

Series C in 2001
This website is for sale! webputty.com is your first and best source for all of the information you’re looking for. From general topics to more of what you would expect to find here, webputty.com has it all. We hope you find what you are searching for!
Spot something off? Help us improve by flagging any incorrect or outdated information. Just email us at support@teaserclub.com. Your feedback is most welcome.